TAE Life Sciences

?? Exciting Partnership Announcement in Cancer Treatment! ?? We are pleased to announce our partnership with Stella Pharma focused on advancing #BNCT to treat cancers. This collaboration aims to bring Steboronine, the world’s first approved boron drug, to new regions and amplify its therapeutic reach, especially for patients facing challenging cancers. Read more about this exciting news --> https://lnkd.in/gtuyDnN3 #Oncology #BNCT #CancerTreatment #Innovation #Targetedtherapy #RadiationOncology #StellaPharm

Exciting news from LSI '24 in Lisbon! Today, our CEO, Rob Hill, shared insights with a room full of investors about our groundbreaking technology for biologically targeted cancer treatment,?#BNCT. We're driving a revolution in cancer care—be a part of the change! #radonc #targetedtherapy #healthcareinnovation #medtech #biotech

Thank you, Med Tech Gurus, for the platform to discuss how our innovation in biologically targeted radiation therapy is driving a new era in cancer treatment. Please listen to the episode and hear from Rob Hill, CEO, to learn more about our journey and the exciting future ahead! ?? #BNCT #cancertreatment #cancerresearch #healthcareinnovation #medtech #biotech #radonc

Today, on World Glioblastoma Day, we reaffirm our unwavering commitment to the fight against #glioblastoma. For everyone with a GBM diagnosis, we at TAE Life Sciences are dedicated to developing boron neutron capture therapy to address the high unmet clinical needs and deliver life-changing treatment to patients worldwide. We stand united with the glioblastoma community—patients, caregivers, and healthcare providers—to provide more promising treatments, better quality of life, and better chances of survival. #glioblastomaday #gbmday #BNCT

We are thrilled to share our partnership with CNAO, bringing #BNCT to cancer patients in Italy and beyond! ?? Check out the video to see the fantastic progress on the facility that will house TAE Life Sciences' #Alphabeam. Watch the video here: https://lnkd.in/de84Bkcb

Harnessing the power of Boron-10, drugs like Boronophenylalanine (BPA) are revolutionizing cancer treatment. Unlike other radiopharmaceuticals, BPA used in Boron Neutron Capture Therapy (BNCT) targets cancer cells with remarkable precision and ???activated only?? when the patient is exposed to a beam of low-energy (epithermal) neutrons. The neutrons interact with the boron-10 atoms, producing high-energy alpha particles and lithium nuclei, effectively destroying cancer cells while sparing surrounding healthy tissue. This precise targeting and localized radiation damage make BNCT a promising, more effective, and less invasive treatment. Stay tuned for updates on how TAE Life Sciences and our novel Boron-10 drugs and BNCT are transforming oncology! ?? #CancerResearch #BNCT #Boron10 #OncologyInnovation #MedicalBreakthroughs

We are thrilled to announce the appointment of our new commercial leadership team and a strategic distribution deal with Radiosurgery Global. These steps will bolster our mission to advance cancer treatment solutions. Together, we will push what’s possible in biologically targeted cancer therapy. Learn more about our latest developments here: https://lnkd.in/eyUWBSsh #BNCT #CancerTherapy #Leadership #Innovation #radonc #biotech #medtech

The TAE Life Sciences team is thrilled to announce our participation at PTCOG! ?? Join us and hear from Chad Lee, our VP of Product, on the performance of our novel tandem accelerator for #BNCT. Don't miss this opportunity to learn about the latest advancements in cancer treatment. See you there! #PTCOG62 #radonc #medtech #biotech #CancerTreatment #MedicalInnovation

#ESTRO24 is here! Join us at Booth #960 today, May 5th, at 11 am for the launch of our innovative new offering. Don't miss this opportunity to discover how #BNCT has the potential to transform the future of cancer care. See you there! #Radiotherapy #RadiationOncology #MedTech #Biotech #radiation #RadOnc #MedPhysics